Your browser doesn't support javascript.
loading
Clinical Characteristics and Outcomes for 7,995 Patients with SARS-CoV-2 Infection.
McPadden, Jacob; Warner, Frederick; Young, H Patrick; Hurley, Nathan C; Pulk, Rebecca A; Singh, Avinainder; Durant, Thomas Js; Gong, Guannan; Desai, Nihar; Haimovich, Adrian; Taylor, Richard Andrew; Gunel, Murat; Cruz, Charles S Dela; Farhadian, Shelli F; Siner, Jonathan; Villanueva, Merceditas; Churchwell, Keith; Hsiao, Allen; Torre, Charles J; Velazquez, Eric J; Herbst, Roy S; Iwasaki, Akiko; Ko, Albert I; Mortazavi, Bobak J; Krumholz, Harlan M; Schulz, Wade L.
Afiliação
  • McPadden J; Department of Pediatrics, Yale School of Medicine, New Haven, CT.
  • Warner F; Department of Pediatrics, Yale School of Medicine, New Haven, CT.
  • Young HP; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
  • Hurley NC; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT.
  • Pulk RA; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
  • Singh A; Department of Computer Science and Engineering, Texas A&M University, College Station, TX.
  • Durant TJ; Corporate Pharmacy Services, Yale New Haven Health, New Haven, CT.
  • Gong G; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
  • Desai N; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT.
  • Haimovich A; Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT.
  • Taylor RA; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT.
  • Gunel M; Interdepartmental Program in Computational Biology and Bioinformatics, Yale University School of Medicine, New Haven, CT.
  • Cruz CSD; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT.
  • Farhadian SF; Yale School of Medicine, New Haven, CT.
  • Siner J; Department of Emergency Medicine, Yale School of Medicine, New Haven, CT.
  • Villanueva M; Department of Genetics, Yale University School of Medicine, New Haven, CT.
  • Churchwell K; Medical Scientist Training Program, Yale University School of Medicine, New Haven, CT.
  • Hsiao A; Yale Center for Genome Analysis, Yale University School of Medicine, New Haven, CT.
  • Torre CJ; Department of Neurosurgery, Yale University School of Medicine, New Haven, CT.
  • Velazquez EJ; Department of Internal Medicine, Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT.
  • Herbst RS; Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT.
  • Iwasaki A; Department of Internal Medicine, Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT.
  • Ko AI; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
  • Mortazavi BJ; Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT.
  • Krumholz HM; Yale New Haven Hospital, New Haven, CT.
  • Schulz WL; Department of Pediatrics, Yale School of Medicine, New Haven, CT.
medRxiv ; 2020 Nov 08.
Article em En | MEDLINE | ID: mdl-32743602
OBJECTIVE: Severe acute respiratory syndrome virus (SARS-CoV-2) has infected millions of people worldwide. Our goal was to identify risk factors associated with admission and disease severity in patients with SARS-CoV-2. DESIGN: This was an observational, retrospective study based on real-world data for 7,995 patients with SARS-CoV-2 from a clinical data repository. SETTING: Yale New Haven Health (YNHH) is a five-hospital academic health system serving a diverse patient population with community and teaching facilities in both urban and suburban areas. POPULATIONS: The study included adult patients who had SARS-CoV-2 testing at YNHH between March 1 and April 30, 2020. MAIN OUTCOME AND PERFORMANCE MEASURES: Primary outcomes were admission and in-hospital mortality for patients with SARS-CoV-2 infection as determined by RT-PCR testing. We also assessed features associated with the need for respiratory support. RESULTS: Of the 28605 patients tested for SARS-CoV-2, 7995 patients (27.9%) had an infection (median age 52.3 years) and 2154 (26.9%) of these had an associated admission (median age 66.2 years). Of admitted patients, 2152 (99.9%) had a discharge disposition at the end of the study period. Of these, 329 (15.3%) required invasive mechanical ventilation and 305 (14.2%) expired. Increased age and male sex were positively associated with admission and in-hospital mortality (median age 80.7 years), while comorbidities had a much weaker association with the risk of admission or mortality. Black race (OR 1.43, 95%CI 1.14-1.78) and Hispanic ethnicity (OR 1.81, 95%CI 1.50-2.18) were identified as risk factors for admission, but, among discharged patients, age-adjusted in-hospital mortality was not significantly different among racial and ethnic groups. CONCLUSIONS: This observational study identified, among people testing positive for SARSCoV-2 infection, older age and male sex as the most strongly associated risks for admission and in-hospital mortality in patients with SARS-CoV-2 infection. While minority racial and ethnic groups had increased burden of disease and risk of admission, age-adjusted in-hospital mortality for discharged patients was not significantly different among racial and ethnic groups. Ongoing studies will be needed to continue to evaluate these risks, particularly in the setting of evolving treatment guidelines.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article